secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001824293-25-000079
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio increases ATM offering capacity by $1.76M after selling $4.55M previously
--------------------------------------------------------------------------------

- Filed prospectus supplement to increase maximum shares issuable under ATM to $1,758,934.
- Previously sold ~$4,546,137 in shares under May 2024 Sales Agreement with H.C. Wainwright.
- Total potential gross proceeds under the ATM program now approximately $6.3 million.
- Shares to be sold at market prices; proceeds for general corporate purposes.
- Legal opinion on share issuance from Mintz Levin attached as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000079/0001824293-25-000079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000079/val-20250523.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer